149 related articles for article (PubMed ID: 32648652)
1. Development of 3D Lymph Node Mimetic for Studying Prostate Cancer Metastasis.
Hakamivala A; Huang Y; Chang YF; Pan Z; Nair A; Hsieh JT; Tang L
Adv Biosyst; 2019 Sep; 3(9):e1900019. PubMed ID: 32648652
[TBL] [Abstract][Full Text] [Related]
2. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
3. The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse model.
Margolin DA; Myers T; Zhang X; Bertoni DM; Reuter BA; Obokhare I; Borgovan T; Grimes C; Green H; Driscoll T; Lee CG; Davis NK; Li L
FASEB J; 2015 Aug; 29(8):3571-81. PubMed ID: 25962655
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study.
Kwon YS; Ha YS; Modi PK; Salmasi A; Parihar JS; Patel N; Faiena I; May M; Lee DI; Llukani E; Patrick T; Rha KH; Ahlering T; Skarecky D; Ahn H; Choi SK; Park S; Jeon SS; Ou YC; Eun D; Manucha V; Albala D; Badani K; Yuh B; Ruel N; Kim TH; Kwon TG; Marchalik D; Hwang J; Kim WJ; Kim IY
BMC Urol; 2015 Aug; 15():79. PubMed ID: 26231860
[TBL] [Abstract][Full Text] [Related]
5. SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development.
Huang KC; Bégin LR; Palanisamy N; Donnelly B; Bismar TA
Urol Oncol; 2016 May; 34(5):235.e1-10. PubMed ID: 26725250
[TBL] [Abstract][Full Text] [Related]
6. Chemokine and chemokine receptors: a comparative study between metastatic and nonmetastatic lymph nodes in breast cancer patients.
Razmkhah M; Jaberipour M; Safaei A; Talei AR; Erfani N; Ghaderi A
Eur Cytokine Netw; 2012; 23(3):72-7. PubMed ID: 23078970
[TBL] [Abstract][Full Text] [Related]
7. Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients.
Chatterjee G; Pai T; Hardiman T; Avery-Kiejda K; Scott RJ; Spencer J; Pinder SE; Grigoriadis A
Breast Cancer Res; 2018 Nov; 20(1):143. PubMed ID: 30458865
[TBL] [Abstract][Full Text] [Related]
8. Presence of prostate cancer metastasis correlates with lower lymph node reactivity.
Gannon PO; Alam Fahmy M; Bégin LR; Djoukhadjian A; Filali-Mouhim A; Lapointe R; Mes-Masson AM; Saad F
Prostate; 2006 Dec; 66(16):1710-20. PubMed ID: 16955408
[TBL] [Abstract][Full Text] [Related]
9. Imaging prostate cancer lymph node metastases with a multimodality contrast agent.
Hall MA; Kwon S; Robinson H; Lachance PA; Azhdarinia A; Ranganathan R; Price RE; Chan W; Sevick-Muraca EM
Prostate; 2012 Feb; 72(2):129-46. PubMed ID: 21538422
[TBL] [Abstract][Full Text] [Related]
10. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.
Gakis G; Boorjian SA; Briganti A; Joniau S; Karazanashvili G; Karnes RJ; Mattei A; Shariat SF; Stenzl A; Wirth M; Stief CG
Eur Urol; 2014 Aug; 66(2):191-9. PubMed ID: 23735200
[TBL] [Abstract][Full Text] [Related]
11. CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro.
Koizumi K; Kozawa Y; Ohashi Y; Nakamura ES; Aozuka Y; Sakurai H; Ichiki K; Doki Y; Misaki T; Saiki I
Oncol Rep; 2007 Jun; 17(6):1511-6. PubMed ID: 17487412
[TBL] [Abstract][Full Text] [Related]
12. Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost-benefit analysis.
Schilling D; Hennenlotter J; Gakis G; Schwentner C; Kuehs U; Stenzl A; Sotlar K
BJU Int; 2012 Sep; 110(6 Pt B):E166-71. PubMed ID: 22314026
[TBL] [Abstract][Full Text] [Related]
13. Site-Specific Polyplex on CCR7 Down-Regulation and T Cell Elevation for Lymphatic Metastasis Blocking on Breast Cancer.
Deng Y; Tan C; Huang S; Sun H; Li Z; Li J; Zhou Z; Sun M
Adv Healthc Mater; 2022 Nov; 11(22):e2201166. PubMed ID: 36113849
[TBL] [Abstract][Full Text] [Related]
14. PCA3 and PSA gene activity correlates with the true tumor cell burden in prostate cancer lymph node metastases.
Tsaur I; Hennenlotter J; Oppermann E; Munz M; Kuehs U; Stenzl A; Schilling D
Cancer Biomark; 2015; 15(3):311-6. PubMed ID: 25769446
[TBL] [Abstract][Full Text] [Related]
15. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
Schiavina R; Borghesi M; Brunocilla E; Manferrari F; Fiorentino M; Vagnoni V; Baccos A; Pultrone CV; Rocca GC; Rizzi S; Martorana G
BJU Int; 2013 Jun; 111(8):1237-44. PubMed ID: 23331345
[TBL] [Abstract][Full Text] [Related]
16. Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma.
Shang ZJ; Liu K; Shao Z
Oral Oncol; 2009 Jun; 45(6):480-5. PubMed ID: 18752985
[TBL] [Abstract][Full Text] [Related]
17. XPNPEP2 is associated with lymph node metastasis in prostate cancer patients.
Li F; Dai Y; Xu H; Huang K; Zhou Y; Luo D; Ma D; Xi L; Lv M; Ma X
Sci Rep; 2019 Jul; 9(1):10078. PubMed ID: 31296901
[TBL] [Abstract][Full Text] [Related]
18. Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients.
Conti A; Santoni M; Burattini L; Scarpelli M; Mazzucchelli R; Galosi AB; Cheng L; Lopez-Beltran A; Briganti A; Montorsi F; Montironi R
World J Urol; 2017 Apr; 35(4):517-526. PubMed ID: 26694187
[TBL] [Abstract][Full Text] [Related]
19. Lymph Nodes and Cancer Metastasis: New Perspectives on the Role of Intranodal Lymphatic Sinuses.
Ji RC
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036019
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation.
Maolake A; Izumi K; Natsagdorj A; Iwamoto H; Kadomoto S; Makino T; Naito R; Shigehara K; Kadono Y; Hiratsuka K; Wufuer G; Nastiuk KL; Mizokami A
Cancer Sci; 2018 May; 109(5):1524-1531. PubMed ID: 29575464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
